Abstract: A biobank is one of the important sources and key links in the realization of translational medicine and precision medicine. The initiation of "Precision Medicine" and "Healthy China 2030" Plan has created an extremely rare opportunity for the development of biobanks. At the same time, it also highlights the problems existing in the biobanks in China, including relevant national standards have not yet been published, implementation of standardized processes and quality control need to be pushed forward, sharing-application mechanism needs to be improved, low-level redundant construction is more serious, self-restoration ability is generally weak, a sustainable development mechanism needs to be explored, and so on. In the past ten years, a lot of pioneering work on the standardization, sharing applications, intensification and sustainable development of biobanks has been done to promote the full application of bio-specimens in biopharmaceutical industry. We have initiated a new era of constructing the standardization of biobanks in China.